Clinical Reviews in Allergy

, Volume 1, Issue 3, pp 385–395 | Cite as

Chemotactic mediators

  • Paul C. Atkins
  • Stephen I. Wasserman


Mast Cell Allergy Clin Immunol Mast Cell Activation Mast Cell Granule Cold Urticaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kline BS, Cohen MB, Rudolph JA: Histologic changes in allergic and nonallergic wheals. J Allergy 3:531–541, 1932CrossRefGoogle Scholar
  2. 2.
    Eidinger D, Wilkinson R, Rose B: A study of cellular responses in immune reactions utilizing the skin window technique. J Allergy 35:77–84, 1964CrossRefGoogle Scholar
  3. 3.
    Fowler JW, Lowell FC: The accumulation of eosinophils as an allergic response to allergen applied to the denuded skin surface. J Allergy 37:19–29, 1966PubMedCrossRefGoogle Scholar
  4. 4.
    Felarca AB, Lowell FC: The accumulation of eosinophils and basophils at skin sites as related to intensity of skin reactivity and symptoms in atopic disease. J Allergy Clin Immunol 48:125–138, 1971PubMedCrossRefGoogle Scholar
  5. 5.
    Atkins PC, Green GR, Zweiman B: Histologic studies of human skin test responses to ragweed, compound 48:80, and histamine. J Allergy Clin Immunol 51:263–273, 1973PubMedCrossRefGoogle Scholar
  6. 6.
    Dunsky EH, Atkins, PC, Zweiman B: Histologic responses in human skin test reactions to ragweed. IV. Effects of a single intravenous injection of steroids. J Allergy Clin Immunol 59:142–146, 1977PubMedCrossRefGoogle Scholar
  7. 7.
    Zweiman B, Slott RI, Atkins PC: Histologic studies of human skin test responses to ragweed and compound 48:80. III. Effects of alternate day steroid therapy. J Allergy Clin Immunol 48:657–663, 1976CrossRefGoogle Scholar
  8. 8.
    Bedard PM, Atkins PC, Zweiman B: Cellular inflammatory response and mediator release after antigen challenge. J Allergy Clin Immunol 69:146, 1982CrossRefGoogle Scholar
  9. 9.
    Dolovich J, Hargreave FE, Chalmers R, Shier KS, Gauldie J, Bienenstock J: J Allergy Clin Immunol 52:388–46, 1973CrossRefGoogle Scholar
  10. 10.
    Robertson DG, Kerigan AT, Hargreave FE, Chalmers R, Dolovich J: Late asthmatic responses induced by ragweed pollen allergen. J Allergy Clin Immunol 54:244–254, 1974PubMedCrossRefGoogle Scholar
  11. 11.
    Solley GO, Gleich GJ, Jordan RE, Schroeter AL: The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 58:408–420, 1976PubMedCrossRefGoogle Scholar
  12. 12.
    Goetzl EJ: Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 65:809–828, 1981PubMedGoogle Scholar
  13. 13.
    Basran GS, Mareley J, Page C, Paul W: Platelet activating factors: A potential mediator of acute and chronic asthma. Clin Res 30:186, 1982Google Scholar
  14. 14.
    Tennenbaum S, Gertel H, Henderson W, Kaliner M: The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J Immunol 125:325–335, 1980Google Scholar
  15. 15.
    Wasserman SI, Soter NA, Center DM, Austen KF: Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60:189–196, 1977PubMedCrossRefGoogle Scholar
  16. 16.
    Atkins PC, Norman ME, Weiner H, Zweiman B: Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. Ann Intern Med 86:415–418, 1977PubMedGoogle Scholar
  17. 17.
    Atkins PC, Zweiman B: Mediator release in local heat urticaria. J Allergy Clin Immunol 68:286–289, 1981PubMedCrossRefGoogle Scholar
  18. 18.
    Soter NA, Wasserman SI, Austen KF, McFadden ER: Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 3302:604–609, 1980Google Scholar
  19. 19.
    Soter NA, Wasserman SI, Pathak MA, Parrish JA, Austen KF: Solar urticaria: Release of mast cell mediators into the circulation after experimental challenge. J Invest Dermatol 72:282, 1979Google Scholar
  20. 20.
    Nagy L: Serum neutrophil chemotactic activity and leukocyte count after house duct induced bronchospasm. Eur J Respir Dis 62:198–203, 1981PubMedGoogle Scholar
  21. 21.
    Lee TH, Nagy L, Nagakura T, Waldort MJ, Kay AB: Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest 69:889–899, 1982PubMedCrossRefGoogle Scholar
  22. 22.
    Atkins PC, Norman ME, Zweiman B: Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate. J Allergy Clin Immunol 62:149–155, 1978PubMedCrossRefGoogle Scholar
  23. 23.
    Orr TSC, Elliott ER, Altounyan REC, Stern MA: Modulation of release of neutrophil chemotactic factor (NCF). Clin Allergy 10:491–496, 1980CrossRefGoogle Scholar
  24. 24.
    Nagy L, Lee TH, Kay AB: Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med 306:497–501, 1982PubMedGoogle Scholar
  25. 25.
    Nagy L: The effect of disodium-cromoglycate on human serum neutrophil chemotactic activity in antigen-induced bronchospasm. Alergia Immunol 27:48–52, 1981Google Scholar
  26. 26.
    Schenkel E, Atkins PC, Yost R, Zweiman B: Antigen-induced neutrophil chemotactic activity from sensitized lung. J Allergy Clin Immunol 70:321–325, 1982PubMedCrossRefGoogle Scholar
  27. 27.
    Atkins PC, Norman ME, Zweiman B, Rosenblum F: Further characterization and biologic activity of ragweed antigen-induced neutrophil chemotactic activity in man. J Allergy Clin Immunol 64:251–258, 1979PubMedCrossRefGoogle Scholar
  28. 28.
    Wasserman SI: Mast cell dependent chemotactic factors in human allergic disease. Proceedings of XIth International Congress of Allergology and Clinical Immunology, in press.Google Scholar
  29. 29.
    Center DM, Soter NA, Wasserman SI, Austen KF: Inhibition of neutrophil Chemotaxis in association with experimental angioedema in patients with cold urticaria: A model of chemotactic deactivation in vivo. Clin Exp Immunol 35:112–118, 1979PubMedGoogle Scholar
  30. 30.
    Valone FH, Goetzl EJ: Immunologic release in the rat peritoneal cavity of lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes. J Immunol 120:102–108, 1978PubMedGoogle Scholar
  31. 31.
    Goetzl EJ: Mediators of immediate hypersensitivity derived from arachidonic acid. N Engl J Med 303:822–824, 1980.PubMedCrossRefGoogle Scholar
  32. 32.
    Peters SP, Shulman ES, MacGlashen DW, Schleimer RP, Hewball HH, Lichtenstein LM: Pharmacologic and biochemical studies of human lung mast cells. J Allergy Clin Immunol 69:150, 1982CrossRefGoogle Scholar
  33. 33.
    Oertel H, Kaliner M: The biologic activity of mast cell granules in rat skin: Effects of adren-ocorticoids on late phase inflammatory responses induced by mast cell granules. J Allergy Clin Immunol 68:238–245, 1981PubMedCrossRefGoogle Scholar
  34. 34.
    Oertel H, Kaliner M: The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing late-phase reactions. J Immunol 127:1398–1402, 1981PubMedGoogle Scholar
  35. 35.
    Kay AB, Stechschulte DJ, Austen KF: An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med 133:602–619, 1971PubMedCrossRefGoogle Scholar
  36. 36.
    Paterson NAM, Wasserman SI, Said JW, Austen KF: Release of chemical mediators from partially purified human lung mast cells. J Immunol 117:1356–1362, 1976PubMedGoogle Scholar
  37. 37.
    Goetzl EJ, Austen KF: Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sei USA 72:4123–4127, 1975CrossRefGoogle Scholar
  38. 38.
    Soter NA, Wasserman SI, Austen KF: Cold urticaria: Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Engl J Med 294:687–690, 1976PubMedGoogle Scholar
  39. 39.
    Wasserman SI, Austen KF, Soter NA: The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria. Clin Exp Immunol 47:570–578, 1982PubMedGoogle Scholar
  40. 40.
    Turnbull LW, Evans DP, Kay AB: Human eosinophils, acidic tetrapeptides (ECF-A) and histamine. Immunology 32:56–63, 1977Google Scholar
  41. 41.
    Anwar ARE, Kay AB: The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature 269:522–524, 1977PubMedCrossRefGoogle Scholar
  42. 42.
    Boswell RN, Austen KF, Goetzl EJ: Intermediate molecular weight-eosinophil chemotactic factors in rat peritoneal mast cells: Immunologic release, granule association, and demonstration of structural heterogeneity. J Immunol 120:15–20, 1978PubMedGoogle Scholar
  43. 43.
    Clark RAF, Gallin JI, Kaplan AP: The selective eosinophil chemotactic activity of histamine. J Exp Med 142:1462–1476, 1975PubMedCrossRefGoogle Scholar
  44. 44.
    Center D: Immunologic release of preformed chemotactic factors for lymphocytes from rat mast cells. Am Rev Respir Dis 119:63, 1979Google Scholar
  45. 45.
    Schatz M, Wasserman SI, Patterson R: Eosinophil and immunologic lung disease. Med Clin North Am 65:1055–1071, 1981PubMedGoogle Scholar
  46. 46.
    Henderson WR, Jorg A, Klebanoff SJ: Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. J Immunol 128:2609–2613, 1982PubMedGoogle Scholar
  47. 47.
    Gleich GJ: The eosinophil: new aspects of structure and function. J Allergy Clin Immunol 60:73–82, 1977PubMedCrossRefGoogle Scholar
  48. 48.
    Davis WB, Hunninghake G, Crystal R: Cytotoxicity of eosinophils for lung parenchymal cells. Clin Res 29:445, 1981Google Scholar
  49. 49.
    Gleich GJ, Loegering DA, Frigas E, Wassom DL, Solley GO, Mann KG: The major basic protein of the eosinophil granule: Physicochemical properties, localization, and function, in Mahmoud AAF, Austen KF, Simon AS (eds): The Eosinophil in Health and Disease. New York, Grune and Stratton Inc, 1980, pp 79–97Google Scholar
  50. 50.
    Virella G, Espinoza A, Patrick A, Colcoell JC: Release of PAF by human PMN exposed to surface fixed immune complexes. Clin Res 30:360, 1982Google Scholar
  51. 51.
    Ayars GH, Altman LC, Rosen H, Martin TR, Doyle TA: Phagocyte-mediated pneumocyte injury. Clin Res 30:426, 1982Google Scholar
  52. 52.
    Flynn PG, Hammerschmidt DE, Redl H, Schlag G, Sheisser A, Jacob HS: Platelet-granulocyte interactions in acute lung injury. Clin Res 30:429, 1982Google Scholar
  53. 53.
    Wintroub B: Inflammation and mediators. Int J Derm 24:436–442, 1980CrossRefGoogle Scholar
  54. 54.
    Atkins PC, Bedard PM, Zweiman B: Skin and systemic mediator release in antigen challenged allergic subjects. J Allergy Clin Immunol 69:94, 1982CrossRefGoogle Scholar
  55. 55.
    Martin GL, Atkins PC, Dunsky EH, Zweiman B: Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. J Allergy Clin Immunol 66:204–212, 1980PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1983

Authors and Affiliations

  • Paul C. Atkins
    • 1
    • 2
  • Stephen I. Wasserman
    • 1
    • 2
  1. 1.From the University of Pennsylvania School of MedicinePhiladelphia
  2. 2.School or Medicine, UCSD Medical CenterUniversity of California, San DiegoSan Diego

Personalised recommendations